Eagle Eye Posted February 17, 2018 Share Posted February 17, 2018 (edited) Any one using Monoclonal Control (immucor reagent ) when performing weak D test or for AB Pos CORD. Are you using one drop or two drop of monoclonal control. Edited February 17, 2018 by Eagle Eye Link to comment Share on other sites More sharing options...
AMcCord Posted February 19, 2018 Share Posted February 19, 2018 The package insert for the control says to use the same test method that is used for the reagent being 'controlled'. If you use 2 drops of anti-D, you should use 2 drops of control. David Saikin 1 Link to comment Share on other sites More sharing options...
mld123 Posted February 19, 2018 Share Posted February 19, 2018 We use monoclonal control and use 1 drop of Anti-D and 1 drop of Monoclonal control. Link to comment Share on other sites More sharing options...
Clarest Posted August 5, 2021 Share Posted August 5, 2021 I have more questions on this topic. 1). Is the monoclonal control only required for AB pos cord but not for full blood grouping test (including forward and reverse grouping)? 2). Is the monoclonal control required for weak D test? For what I understand, the monoclonal control is mainly used to detect spontaneous agglutination that could cause mistyping. If your RhD typing at immediate-spin is negative (or even there is negative reaction with ant-A and/or anti-B reagent), does that prove there is no spontaneous agglutination? If yes, what's the purpose of using monoclonal control in the weak D test? Link to comment Share on other sites More sharing options...
Ensis01 Posted August 5, 2021 Share Posted August 5, 2021 It is used to provide a negative control for the forward grouping, but is therefore only needed for AB pos patients. It is usually/often easier to require the control every time so it is not forgotten when the occasional AB pos does occur. The control's use in weak D testing is useful when the patient has a positive DAT. Malcolm Needs and AMcCord 2 Link to comment Share on other sites More sharing options...
Clarest Posted August 7, 2021 Share Posted August 7, 2021 On 8/5/2021 at 3:32 AM, Ensis01 said: It is used to provide a negative control for the forward grouping, but is therefore only needed for AB pos patients. It is usually/often easier to require the control every time so it is not forgotten when the occasional AB pos does occur. The control's use in weak D testing is useful when the patient has a positive DAT. Thank you Ensis01 for your response. We do not do weak D testing if the patient has a positive DAT. We only do weak D testing on the cord blood samples when possible. However, I would like to know how you would interpret the weak D testing when the patient has a positive DAT. Based on the inserts of the RhD typing reagents we used, there are the following statements. "An Indirect Antiglobulin Test result with cells that demonstrate a positive Direct Antiglobulin Test cannot be reliably interpreted with respect to weak D." "A positive Indirect Antiglobulin Test for weak D must be validated by a macroscopically negative direct antiglobulin test or a negative indirect antiglobulin test using an appropriate control." Red blood cells coated with alloantibodies or autoantibodies of the same or similar specificity as the reagent (i.e., cells that are DAT positive) may give weak reactions. This is due to decreased availability of antigen sites because of antigen blocking or steric hindrance. In extreme cases, false-negative results may occur. Link to comment Share on other sites More sharing options...
Ensis01 Posted August 7, 2021 Share Posted August 7, 2021 32 minutes ago, Clarest said: Thank you Ensis01 for your response. We do not do weak D testing if the patient has a positive DAT. We only do weak D testing on the cord blood samples when possible. However, I would like to know how you would interpret the weak D testing when the patient has a positive DAT. Based on the inserts of the RhD typing reagents we used, there are the following statements. "An Indirect Antiglobulin Test result with cells that demonstrate a positive Direct Antiglobulin Test cannot be reliably interpreted with respect to weak D." "A positive Indirect Antiglobulin Test for weak D must be validated by a macroscopically negative direct antiglobulin test or a negative indirect antiglobulin test using an appropriate control." Red blood cells coated with alloantibodies or autoantibodies of the same or similar specificity as the reagent (i.e., cells that are DAT positive) may give weak reactions. This is due to decreased availability of antigen sites because of antigen blocking or steric hindrance. In extreme cases, false-negative results may occur. If the DAT is positive I would not do weak D testing unless I could obtain a negative DAT. The primary methods I have used to do this are: EGA and CPD. I have however used 56’C heat elation for cord and neonate samples with some success, it is however time consuming. Link to comment Share on other sites More sharing options...
Recommended Posts
Create an account or sign in to comment
You need to be a member in order to leave a comment
Create an account
Sign up for a new account in our community. It's easy!
Register a new accountSign in
Already have an account? Sign in here.
Sign In Now